Announcements Trials
Browse Landscape

Phase

Phase 2 5Phase 1 3Phase 3 2Phase EARLY_PHASE1 1Phase 2/3 1

Status

Completed 3Terminated 1Active not recruiting 1

Sponsor Class

OTHER 5INDUSTRY 5

Study Type

Interventional 5

Sponsor

Cancer Type

Thoracic 5

Conditions

Breast Neoplasms 1888Carcinoma, Non-Small-Cell Lung 1348Prostatic Neoplasms 980Colorectal Neoplasms 851Multiple Myeloma 741Leukemia, Myeloid, Acute 725Neoplasms 691Lung Neoplasms 679Neoplasm Metastasis 642Lymphoma 579Carcinoma, Hepatocellular 571Pancreatic Neoplasms 566Stomach Neoplasms 522Leukemia 511Recurrence 493Leukemia, Lymphocytic, Chronic, B-Cell 459Precursor Cell Lymphoblastic Leukemia-Lymphoma 452Melanoma 451Lymphoma, Non-Hodgkin 442Ovarian Neoplasms 426Lymphoma, Large B-Cell, Diffuse 423Squamous Cell Carcinoma of Head and Neck 416Myelodysplastic Syndromes 416Head and Neck Neoplasms 403Brain Neoplasms 403Rectal Neoplasms 397Glioblastoma 375Carcinoma, Renal Cell 350Hodgkin Disease 338Esophageal Neoplasms 337

Interventions

Pemetrexed 2pembrolizumab 1paclitaxel poliglumex 1atezolizumab 1Nivolumab 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase 2 × OTHER × Advanced Non-small Cell Lung Cancer × Clear all
NCT04699123 2025-05-13

The Study of NC318 Alone or in Combination With Pembrolizumab in Patients With Advanced Non-small Cell Lung Cancer

Yale University

Phase 2 Active not recruiting
159 enrolled
Thoracic

Advanced Non-small Cell Lung Cancer

NCT04263051 2025-02-05

Optim-UCPVax

Centre Hospitalier Universitaire de Besancon

Phase 2 Completed
60 enrolled
Thoracic

Advanced Non-small Cell Lung Cancer

NCT03014648 2023-12-13

Evaluating the Efficacy of Atezolizumab in Advanced Non-small Cell Lung Cancer (NSCLC)

University of Pittsburgh

Phase 2 Completed
28 enrolled 22 charts
Thoracic

Advanced Non-small Cell Lung Cancer

NCT02200354 2019-08-14

The Safety and Efficacy of Pemetrexed Rechallenge With Bevacizumab

Kobe City General Hospital

Phase 2 Terminated
20 enrolled
Thoracic

Advanced Non-small Cell Lung Cancer

NCT00487669 2014-01-09

Phase II Study of Combination of Paclitaxel Poliglumex and Alimta for Advanced Non-small Cell Lung Cancer (NSCLC)

Dartmouth-Hitchcock Medical Center

Phase 2 Completed
14 enrolled 8 charts
Thoracic

Advanced Non-small Cell Lung Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡